Get Male Breast Screening Treatment Online

Yes. Male breast cancer is rare, representing about 1% of all breast cancer cases, but it does occur. Risk factors include older age, obesity, elevated estrogen levels, BRCA2 gene mutations, Klinefelter syndrome, liver disease, and certain medications. Any new or persistent breast lump in a man should be evaluated promptly.

Gynecomastia is a benign enlargement of male breast glandular tissue caused by a hormonal imbalance between estrogen and testosterone. Male breast cancer typically presents as a firm, painless, eccentric lump often beneath or beside the nipple, sometimes with nipple retraction or discharge. Only a clinical evaluation and imaging can reliably distinguish the two.

You should seek evaluation if you notice a new lump or thickening in breast tissue, nipple discharge (especially bloody), nipple inversion or skin changes such as redness or dimpling, persistent breast pain, or swollen lymph nodes under the arm. Early evaluation is always preferable.

A clinician will review your symptoms, duration, and progression, along with your personal and family medical history, current medications, and relevant risk factors. Based on the assessment, the physician may recommend imaging such as ultrasound or mammography, blood tests for hormone levels, or referral to a specialist for biopsy if warranted.

Several medication classes are associated with gynecomastia, including spironolactone, certain antipsychotics, some antifungals, anabolic steroids, opioids, and some heart medications. If you suspect a medication is causing breast changes, do not stop it without speaking to your doctor first, as an evaluation can help identify the cause.

For gynecomastia that is recent in onset and causing discomfort, physicians may consider off-label use of medications such as tamoxifen or anastrozole to reduce breast tissue enlargement driven by hormonal imbalance. Treatment depends on the underlying cause, duration, and severity, and surgical referral may be appropriate in long-standing cases.

Doctronic uses an AI-powered evaluation to gather detailed information about your symptoms, history, and risk factors. A licensed physician then reviews your case, interprets the information, and provides a personalized treatment plan or referral recommendation. The entire process is designed to be thorough, efficient, and conducted under physician oversight.

Yes. Doctronic connects patients with licensed, board-eligible physicians, and all cases are doctor-reviewed and subject to clinical audit. The platform is HIPAA-compliant, protecting your personal and health information. Doctronic is available to adults 18 and older in any U.S. state.